Re-programming utrophin gene expression in DMD using artificial transcription factors

Autor: 1 Passananti C, 2 Mattei E, 2 Strimpakos G, 1 Onori A, 1 Pisani C, 3 Monaco L, 2 Luvisetto S, 2 Severini C, 2 Farioli-Vecchioli S, 2 Gabanella F, 2 Burelli G, 1 Delle Monache F, 2 Di Certo MG, 1 Corbi N.

Publikováno v: The Batsheva de Rothschild Workshop on Skeletal and Cardiac Myogenesis, Weizmann Institute of Science, Rehovot, Israel, 6-11/03/2016
info:cnr-pdr/source/autori:1 Passananti C, 2 Mattei E, 2 Strimpakos G, 1 Onori A, 1 Pisani C, 3 Monaco L, 2 Luvisetto S, 2 Severini C, 2 Farioli-Vecchioli S, 2 Gabanella F, 2 Burelli G, 1 Delle Monache F, 2 Di Certo MG, 1 Corbi N./congresso_nome:The Batsheva de Rothschild Workshop on Skeletal and Cardiac Myogenesis/congresso_luogo:Weizmann Institute of Science, Rehovot, Israel/congresso_data:6-11%2F03%2F2016/anno:2016/pagina_da:/pagina_a:/intervallo_pagine

Up-regulation of the dystrophin-related gene utrophin represents a promising therapeutic strategy for the treatment of Duchenne muscular dystrophy (DMD). The strategy is based on the capacity of utrophin to functionally replace defective dystrophin.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::c553085a1f70d7999c35a3943a9ce428
https://publications.cnr.it/doc/383200